Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2021
Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.
Journal: Schizophrenia research
Published: November 29, 2017
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 14, 2017
Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance Spectroscopy.
Journal: JAMA psychiatry
Published: June 16, 2016
History of the Concept of Disconnectivity in Schizophrenia.
Journal: Harvard review of psychiatry
Published: March 09, 2016
Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.
Journal: JAMA psychiatry
Published: October 02, 2014
Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.
Journal: Schizophrenia research
Published: August 25, 2014
In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.
Journal: Neurobiology of disease
Published: July 03, 2014
Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.
Journal: Handbook of experimental pharmacology
Published: October 03, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026